Keir C - Search Results

1

Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.

Kopetz S, Grothey A, Yaeger R, Van Cutsem E, Desai J, Yoshino T, Wasan H, Ciardiello F, Loupakis F, Hong YS, Steeghs N, Guren TK, Arkenau HT, Garcia-Alfonso P, Pfeiffer P, Orlov S, Lonardi S, Elez E, Kim TW, Schellens JHM, Guo C, Krishnan A, Dekervel J, Morris V, Calvo Ferrandiz A, Tarpgaard LS, Braun M, Gollerkeri A, Keir C, Maharry K, Pickard M, Christy-Bittel J, Anderson L, Sandor V, Tabernero J. Kopetz S, et al. Among authors: keir c. N Engl J Med. 2019 Oct 24;381(17):1632-1643. doi: 10.1056/NEJMoa1908075. Epub 2019 Sep 30. N Engl J Med. 2019. PMID: 31566309 Clinical Trial.

2

Treatment patterns, prescribing decision drivers, and predictors of complete response following disease recurrence in gastrointestinal stromal tumor patients-a chart extract-based approach.

Conley AP, Guerin A, Sasane M, Gauthier G, Schwiep F, Keir CH, Wu EQ. Conley AP, et al. J Gastrointest Cancer. 2014 Dec;45(4):431-40. doi: 10.1007/s12029-014-9600-4. J Gastrointest Cancer. 2014. PMID: 24847952

3

Comparison of the long-term risk of recurrence and other clinical outcomes in GIST patients receiving imatinib as adjuvant therapy--a retrospective chart extract-based approach.

Conley AP, Guérin A, Sasane M, Gauthier G, Schwiep F, Keir CH, Wu EQ. Conley AP, et al. J Gastrointest Cancer. 2013 Jun;44(2):190-8. doi: 10.1007/s12029-012-9467-1. J Gastrointest Cancer. 2013. PMID: 23229801 Free PMC article.

4

Physician Underestimation of the Risk of Gastrointestinal Stromal Tumor Recurrence After Resection.

Guérin A, Sasane M, Keir CH, Gauthier G, Macalalad AR, Wu EQ, Conley AP. Guérin A, et al. JAMA Oncol. 2015 Sep;1(6):797-805. doi: 10.1001/jamaoncol.2015.2407. JAMA Oncol. 2015. PMID: 26204106

5

The economic burden of gastrointestinal stromal tumor (GIST) recurrence in patients who have received adjuvant imatinib therapy.

Guerin A, Sasane M, Gauthier G, Keir CH, Zhdavana M, Wu EQ. Guerin A, et al. J Med Econ. 2015 Mar;18(3):241-8. doi: 10.3111/13696998.2014.991787. Epub 2014 Dec 5. J Med Econ. 2015. PMID: 25422992 Free article.

6

Impact of low-grade adverse events on health-related quality of life in adult patients receiving imatinib or nilotinib for newly diagnosed Philadelphia chromosome positive chronic myelogenous leukemia in chronic phase.

Guérin A, Chen L, Ionescu-Ittu R, Marynchenko M, Nitulescu R, Hiscock R, Keir C, Wu EQ. Guérin A, et al. Among authors: keir c. Curr Med Res Opin. 2014 Nov;30(11):2317-28. doi: 10.1185/03007995.2014.944973. Epub 2014 Aug 5. Curr Med Res Opin. 2014. PMID: 25025755 Clinical Trial.

7

Evaluating the Impact of a Switch to Nilotinib on Imatinib-Related Chronic Low-Grade Adverse Events in Patients With CML-CP: The ENRICH Study.

Cortes JE, Lipton JH, Miller CB, Busque L, Akard LP, Pinilla-Ibarz J, Keir C, Warsi G, Lin FP, Mauro MJ. Cortes JE, et al. Among authors: keir c. Clin Lymphoma Myeloma Leuk. 2016 May;16(5):286-96. doi: 10.1016/j.clml.2016.02.002. Epub 2016 Feb 16. Clin Lymphoma Myeloma Leuk. 2016. PMID: 26993758 Free PMC article. Clinical Trial.

8

Long-Term Safety Follow-Up of Subjects Previously Treated with Non-Replicating Retroviral Vector-Based Gene Therapies.

Mohanlal R, Qiu Y, Zheng M, Mirkou A, Sridharan K, Keir C. Mohanlal R, et al. Among authors: keir c. Mol Diagn Ther. 2016 Dec;20(6):591-602. doi: 10.1007/s40291-016-0229-9. Mol Diagn Ther. 2016. PMID: 27435702 Free PMC article.

9

Survival after stem-cell transplant in pediatric and young-adult patients with relapsed and refractory B-cell acute lymphoblastic leukemia.

Crotta A, Zhang J, Keir C. Crotta A, et al. Among authors: keir c. Curr Med Res Opin. 2018 Mar;34(3):435-440. doi: 10.1080/03007995.2017.1384373. Epub 2017 Oct 24. Curr Med Res Opin. 2018. PMID: 28945102

10

Building blocks for institutional preparation of CTL019 delivery.

McGuirk J, Waller EK, Qayed M, Abhyankar S, Ericson S, Holman P, Keir C, Myers GD. McGuirk J, et al. Among authors: keir c. Cytotherapy. 2017 Sep;19(9):1015-1024. doi: 10.1016/j.jcyt.2017.06.001. Epub 2017 Jul 25. Cytotherapy. 2017. PMID: 28754600 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page